Context: Methods to directly measure insulin resistance are invasive, complex, and costly. Surrogate indexes derived from the oral glucose tolerance test (OGTT) have been developed, but few studies have systematically analyzed these indexes.
I
nsulin resistance is an important risk factor for cardiovascular disease and diabetes and a key determinant of clustering of cardiovascular risk factors (1) (2) (3) . Methods to directly measure insulin resistance are invasive, complex, and costly. Therefore, surrogate indexes have been developed using insulin and/or glucose levels in the fasted state alone (4 -12) or in combination with insulin and glucose levels at various oral glucose tolerance test (OGTT) sampling times as well as with other metabolic variables (4, 8, 9, (13) (14) (15) (16) (17) (18) (19) . Few studies, however, have systematically compared these indexes using as reference a direct measure of insulin resistance (2, 8) . Thus, this study had a 2-fold objective: 1) to compare surrogate indexes with the gold standard, directly measured insulin sensitivity by the euglycemic-hyperinsulinemic clamp, and 2) to examine the relationship of surrogate and direct measures of insulin resistance with cardiovascular risk factors.
Subjects and Methods
A total of 348 Finnish offspring of type 2 diabetic individuals aged 25-50 yr living in Kuopio, Finland, were enrolled in the validation study cohort of the Metabolic Syndrome in Men study (20) . The validation study was designed to compare OGTT-derived indexes of insulin secretion and insulin sensitivity with parameters measured by the iv glucose tolerance test and euglycemic-hyperinsulinemic clamp. Validated OGTT-derived indexes were used in the analysis of Metabolic Syndrome in Men study data, an ongoing population-based cross-sectional study among men aged 45-70 yr randomly selected from the population register of the town of Kuopio in Eastern Finland (20) . The study was approved by the ethics committee of the University of Kuopio and Kuopio University Hospital and was in accordance with the Helsinki Declaration. Study methods have been described elsewhere (20) . Briefly, an OGTT (75 g glucose) was administered, and venous blood samples were drawn at 0, 30, 60, 90, and 120 min. We used the trapezoidal method to calculate the area under the glucose and insulin curves. Definitive measures of fat distribution were obtained by computed tomography (Siemens Volume Zoom, Forchheim, Germany) at the level of the fourth lumbar vertebra (21) . Subcutaneous and intraabdominal fat areas were calculated as previously described (22) .
We assessed glucose tolerance status using the 2003 American Diabetes Association criteria. Diabetes was defined as fasting plasma glucose concentration of at least 7.0 mmol/liter and/or 2-h plasma glucose concentration of at least 11.1 mmol/liter, impaired fasting glucose (IFG) as fasting glucose concentration of 5.6 to less than 7.0 mmol/liter, and impaired glucose tolerance (IGT) as 2-h glucose concentration of 7.8 to less than 11.1 mmol/ liter (23) . Individuals treated with glucose-lowering medications were considered to have diabetes. The 10-yr risk of coronary heart disease was estimated by Framingham risk equations (24) . The metabolic syndrome was defined according to the 2005 American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (25) .
In 287 nondiabetic participants, insulin sensitivity was directly measured by euglycemic-hyperinsulinemic clamp for 120 min. Using clamp data from the last 60 min, whole-body glucose uptake was expressed as steady-state glucose disposal per kilogram lean body mass divided by steady-state insulin concentrations (M LBM /I). Relevant information was missing in 15 participants. Therefore, this study presents information on 272 nondiabetic individuals. Surrogate indexes of insulin sensitivity were calculated according to published formulas (Table 1 and Supplemental Material, published on The Endocrine Society's Journals Online web site at http://jcem.endojournals.org) (4 -19) .
Statistical analysis
Statistical analyses were performed using SAS statistical software (version 9.1; SAS Institute Inc., Cary, NC). Continuous and dichotomous variables were compared using one-way analysis of covariance and logistic regression analysis, respectively. Spearman correlation coefficients were used to analyze the strength of (8) I 120 /G 120 ISI 2h (9) 10 4 /(I 120 ϫ G 120 ) Gutt's ISI 0,120 (14) (m/͓(G 0 ϩ G 120 )/2͔)/log ͓(I 0 ϩ I 120 )/2͔ the relationship between indices of insulin resistance. Correlation coefficients were compared by the T2 method (26) . The ability of each index to detect individuals with the metabolic syndrome or M LBM /I-defined insulin resistance was assessed by the area under the receiver operating characteristic curve (AUC). Statistical differences between AUC were determined by the method developed by DeLong et al. (27) . The impact of sex, body mass index (BMI), and glucose tolerance status on the relation of M LBM /I, Matsuda index, and homeostasis model assessment of insulin resistance (HOMA IR) to selected metabolic variables was assessed by linear regression analysis.
Results
Men had more central adiposity and dyslipidemia than women (Table 2) . Men also had higher Matsuda index, fasting glucose concentration, blood pressure, and Framingham risk score. Conversely, women had more sc fat and higher levels of 2-h insulin, adiponectin, and fibrinogen. No significant differences according to sex were observed for age, BMI, fasting insulin, 2-h glucose, C-reactive protein, M LBM /I, and prevalent metabolic syndrome.
Correlations of surrogate indexes of insulin resistance with M LBM /I
Indices derived from fasting values had strong correlations with M LBM /I across sex, glucose tolerance, and BMI categories (Table 3) . Matsuda index had a stronger correlation with M LBM /I than did the other indexes except for simple index assessing insulin sensitivity using OGTT measurements (SI IS OGTT) and Avignon's insulin sensitivity index (Avignon's SiM).
Ability of indexes to detect individuals with metabolic syndrome or low M LBM /I
The AUC of McAuley, Avignon's SiM, Stumvoll's metabolic clearance rate of glucose using OGTT measurements (MCR OGTT ), and Stumvoll's insulin sensitivity index using OGTT measurements (ISI OGTT ) for identifying individuals with the metabolic syndrome were greater than the AUC of M LBM /I ( Table 4 ). The AUC of the other indexes were comparable to that of M LBM /I except for the 2-h insulin-to-glucose ratio (IGR 2h ). Most surrogate indexes (excluding fasting and 2-h glucose, IGR 2h , and ISI 2h ) were similar to Matsuda index in their ability to detect subjects in the lower M LBM /I quartile.
Relation of measures of obesity and fasting and 2-h insulin and glucose levels to M LBM /I
Directly measured intraabdominal fat was no more strongly correlated with M LBM /I than was waist circumference (r ϭ Ϫ0.49 vs. Ϫ0.51; P ϭ 0.607) and BMI (r ϭ Ϫ0.51; P ϭ 0.410) ( Table 5) . Subcutaneous fat had a weaker correlation with M LBM /I than did BMI (r ϭ Ϫ0.41 vs. Ϫ0.51; P ϭ 0.012). Fasting and 2-h insulin levels were similarly related to M LBM /I (r ϭ Ϫ0.72 vs. Ϫ0.66; P ϭ 0.088), and so were fasting and 2-h glucose levels (r ϭ Ϫ0.32 vs. Ϫ0.37; P ϭ 0.487).
Surrogate indices as compared with M LBM /I in their relation to metabolic variables
Indexes based on fasting measurements were mostly similar to M LBM /I in their relationships with metabolic variables (Table 5) . However, the correlation of McAuley index with lipoproteins and Framingham risk score was particularly strong. In general, fasting-derived indexes had more robust correlations with fasting insulin and glucose concentrations than did M LBM /I. Indexes based on OGTT sampling times were also largely similar to M LBM /I but were more strongly related to 2-h insulin and glucose levels. In addition, some OGTT-derived indexes had distinctive correlations relative to those of M LBM /I. Matsuda index had more robust relationships with blood pressure and fasting insulin and glucose levels. Indexes with a measure of adiposity in their formula, such as Avignon's SiM, Stumvoll with demographics, and Stumvoll MCR OGTT , had stronger correlations with adiposity, blood pressure, fasting insulin concentration, fibrinogen, and Framingham risk score.
There was no interaction effect of sex, glucose tolerance, and BMI on the relation of M LBM /I, Matsuda index, and HOMA IR to selected metabolic variables and Framingham risk score (Fig. 1) .
Discussion
In nondiabetic Finnish offspring of type 2 diabetic individuals, indexes derived from either fasting values or OGTT sampling times are valid measures of insulin resistance across sex, glucose tolerance, and BMI categories. However, Matsuda index along with SI IS OGTT and Avignon's SiM correlate better with directly measured insulin sensitivity by euglycemic-hyperinsulinemic clamp than do the other surrogate indexes. In addition, the strength by which most surrogate indexes correlate with cardiovascular risk factors is similar to the corresponding correlation of directly measured insulin sensitivity.
Studies that compare surrogate and direct indexes have suggested that surrogate indexes are adequate measures of insulin resistance (4, 8, 18, 19, 28) . Nevertheless, few studies have carried out systematic comparisons in large datasets to determine which index is best (2, 8) . In a previous analysis of three epidemiological studies, we reported that Avignon's SiM, Belfiore's ISI(gly) area , ISI 2h , and Stumvoll with demographics had the most robust correlations with ISI measured by the frequently sampled iv glucose tolerance test with minimal model analysis, but Gutt's ISI 0,120 consistently showed the strongest prediction of future diabetes (2) . SI IS OGTT and Matsuda were not examined because of the OGTT sampling time requirements by their formulas. In the original description of the Matsuda index, Matsuda index was superior to Gutt's ISI 0,120 and Belfiore's indexes in their correlation with M LBM /I (19). Conversely, Piché et al. (29) described stronger correlations for surrogate indexes based on OGTT sampling times and a measure of adiposity (such as Gutt's ISI 0,120 and Stumvoll's MCR OGTT and ISI OGTT ) than for indexes derived form fasting measurements alone or lacking a measure of adiposity (such as HOMA IR and Matsuda index). In these last two studies, however, comparisons between indexes were not sustained by statistical analyses. Our present re- Although inferior to the Matsuda index, all indexes have strong correlations with directly measured insulin sensitivity. Earlier studies differ on the optimal surrogate index of insulin resistance (2, 18, 19, 29) . Reasons for the discrepancies may be multiple: inadequate suppression of endogenous glucose production of the liver by some euglycemic-hyperinsulinemic clamp protocols or other methods to directly measure insulin resistance, characteristics of the study population particularly glucose tolerance abnormalities and obesity, sample size, and selection of surrogate indexes. Despite the disagreement, consensus exists on the validity of surrogate indexes as adequate measures of insulin resistance for clinical and epidemiological studies (2, 4, 8, 18, 19, 28) . Furthermore, indexes derived from fasting measurements including fasting insulin concentration and HOMA IR display robust correlations with directly measured insulin sensitivity (4, 18, 28 0, 120 , which also includes a measure of adiposity in its formula, has a pattern of associations largely similar to that of M LBM /I. Consequently, some indexes may signal not only insulin resistance but also other important domains for diabetes and cardiovascular disease such as ␤-cell dysfunction, hepatic glucose production, dyslipidemia, and adiposity (2) . Whether this is relevant for predicting future cardiovascular disease is not known, but it appears not essential for predicting conversion to diabetes. In our previous report, Gutt's ISI 0,120 , Belfiore's ISI(gly) area , Avignon's SiM, and QUICKI had the best overall ability to predict the development of diabetes (2) .
Limitations of the present study include analysis of a Caucasian study sample (lean, relatively young nondiabetic offspring of type 2 diabetic individuals), which limits applicability to other groups of individuals. Many of these groups differ in terms of diabetic and cardiovascular risks as well as sociodemographic, lifestyle, anthropometric, and metabolic characteristics. Therefore, additional studies are needed to validate our findings particularly in highrisk populations such as South Asians, Hispanics, and Blacks. Another significant limitation is the lack of prospective data, which precludes any speculation about cause and temporal relationships.
In summary, surrogate indexes are valid measures of insulin resistance, although Matsuda index, SI IS OGTT, and Avignon's SiM display the strongest correlations with directly measured insulin sensitivity. Thus, multiple sampling times during an OGTT may not be mandatory to adequately estimate insulin resistance in clinical and epidemiological studies. Similarly, most surrogate indexes including those derived from fasting measurements are comparable to directly measured insulin sensitivity in their relation to cardiovascular risk factors and definitive measures of fat distribution. Further studies are needed to compare surrogate and direct indexes in their ability to predict diabetes and cardiovascular disease.
